Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IVUS (intravascular ultrasound) detects transplant rejection:

This article was originally published in Clinica

Executive Summary

Analysis of signals from intravascular ultrasound (IVUS) may be useful in determining the likelihood of transplant rejection, according to animal studies. Researchers at Stanford University School of Medicine in California, analysed radiofrequency signals from IVUS examinations of transplanted aortic grafts in six monkeys. They found a significant difference in signal intensity between the allograft and host aorta using a technique whereby RF signals are acquired in real time using a 500MHz digitiser with 8-bit resolution. Their results are published in the November edition of Circulation. The same difference could not be seen with conventional IVUS gray-scale images.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT080128

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel